Buspirone anti-anxiety method
Patent 4182763 Issued on January 8, 1980. Estimated Expiration Date: 
May 22, 1998. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
May 22, 1998. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 3717634 Tranquilizer process employing N-(heteroarcyclic)piperazinylalkylazaspiroalkanediones Patent #: 3976776 InventorsAssigneeApplicationNo. 05/908597 filed on 05/22/1978US Classes:514/252.15Spiro ring system containingExaminersPrimary: Friedman, Stanley J.Attorney, Agent or FirmInternational ClassA61K 31/505 (20060101)AbstractBuspirone hydrochloride is an effective anti-anxiety agent for the palliative treatment of neurotic patients in which symptoms of anxiety are predominant at doses which are without observable effect in either normal individuals or psychotic patients.Other References
| |
